Skip to main content
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.705
-0.195 (-3.98%)
May 14, 2025, 2:00 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gvoke, Keveyis and Recorlev
153.36M
Log In
Log In
Log In
Log In
Upgrade
Gvoke, Keveyis and Recorlev Growth
40.36%
Log In
Log In
Log In
Log In
Upgrade
Royalty, Contract and Other
10.55M
Log In
Log In
Log In
Log In
Upgrade
Royalty, Contract and Other Growth
971.07%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
163.91M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
48.68%
Log In
Log In
Log In
Log In
Upgrade